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Abstract. Optical clearing, in combination with recently
developed optical imaging techniques, enables visualiza-
tion and acquisition of high-resolution, three-dimensional
images of biological structures deep within the tissue.
Many different approaches can be used to reduce light
absorption and scattering within the tissue, but there is
a paucity of research on the quantification of clearing
efficacy. With the use of a custom-made spectroscopy sys-
tem, we developed a way to quantify the quality of clearing
in biological tissue and applied it to the mouse brain. Three
clearing techniques were compared: BABB (1:2 mixture of
benzyl alcohol and benzyl benzoate, also known as
Murray’s clear), pBABB (peroxide BABB, a modification
of BABB which includes the use of hydrogen peroxide),
and passive CLARITY. We found that BABB and
pBABB produced the highest degree of optical clearing.
Furthermore, the approach allows regional measurement
of light attenuation to be performed, and our results show
that light is most attenuated in regions with high lipid con-
tent. We provide a way to choose between the multiple
clearing protocols available, and it could prove useful for
evaluating images that are acquired with cleared tissues.
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1 Introduction
The ability to analyze tissue in three dimensions (3-D) at the
mesoscopic scale has proven essential in the study of healthy
and diseased organisms and organs. Techniques such as ex vivo
magnetic resonance imaging and x-ray computed tomography
(CT) have been successful in a number of applications, but
are limited by low resolution or inability to use common staining
techniques. These limitations are overcome by optical imaging
techniques such as optical projection tomography1 and light
sheet fluorescence microscopy.2 However, to allow for sufficient
depth penetration, these imaging techniques require specimens
to be rendered transparent via a process known as optical
clearing, which can be achieved using a number of techniques.
In general, these techniques aim to minimize scattering and
absorption of both illumination and detection light within the
sample and can achieve light penetration increase up to several
millimeters.3 Light in the body is absorbed by structures such as
red blood cells and is scattered at the interface of materials with
different refractive indices. Some approaches obtain refractive
index matching by replacing extracellular water (n ≈ 1.35) with
solutions with a higher refractive index, closer to that of the cell
membrane (n ≈ 1.46). As lipids are the main scatterers in bio-
logical tissue,4 other approaches obtain a uniform refractive
index by their removal.5
In this paper, the efficiency of three clearing techniques is
compared: BABB (1:2 mixture of benzyl alcohol and benzyl
benzoate, also known as Murray’s clear),3 pBABB (a modifica-
tion of BABB with hydrogen peroxide), and passive
CLARITY,6,7 A new method for measuring the clearing degree
using a custom-made spectroscopy system was developed and
used to evaluate the obtained transparency in the mouse brain.
Similar measurements can be acquired with optical CT,8 but the
depth of this modality might be not suitable for some samples. In
this paper, three regions of the mouse brain were studied: olfac-
tory bulb, pons, and cerebellum. These areas differ in their
microscopic structures and amounts of myelin, which surrounds
the axons and has a high lipid content. The absorption spectra
for each of the mouse brain regions and for each clearing method
were compared and used for quantification of the quality of
clearing. Moreover, the change in the sizes of the samples
induced by each clearing technique was also evaluated.
2 Methods
All experimental study protocols were conducted in accordance
with institutional, UK home office regulations. MF1 nu∕numice
were individually heparinized and terminally anesthetized. Once
anesthesia was confirmed, surgical procedures for intracardial
perfusion were performed for systemic clearance of blood.
Thirty milliliters of phosphate buffered saline (PBS) (37°C)
were administered at a flow rate of 5 ml∕min, followed by ad-
ministration of 40 ml of 4% formaldehyde solution. The brains
were extracted and postfixed for 12 h in 4% formaldehyde (4°C),
then rinsed in PBS, and sliced to obtain 2 mm sagittal slices. The
two central slices close to the midline, one per hemisphere, were
used for the light attenuation quantitation study. For each clear-
ing technique, between 6 and 12 mice were evaluated. Tissues
were then optically cleared with three procedures. For BABB
clearing, samples were dehydrated in methanol (MeOH) for 48 h
at room temperature and transferred for clearing in BABB (1:2
mixture of benzyl alcohol and benzyl benzoate) for 48 h. For
clearing with pBABB, samples were first treated with a solution
known as Dent’s bleach, which comprises a 4:1:1 combination
of MeOH, dimethyl sulfoxide (DMSO), and hydrogen peroxide.
This solution was applied prior to dehydration with MeOH and
clearing with BABB. Dent’s bleach is widely used for whole-
mount immunohistochemistry, where hydrogen peroxide is
important to block endogenous peroxidase activity and DMSO
to enhance tissue penetration,9 but to the authors’ knowledge, it
has not previously been used for optical clearing. The samples
cleared with CLARITY were prepared according to the passive
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protocol,7 which aims to remove lipids by passive thermal clear-
ing (37°C) and preserve tissue structure by hydrogel embedding.
Light transmission spectra were acquired with a custom-
made spectroscopic system in three areas of the brain: pons, cer-
ebellum, and olfactory bulb (Fig. 1).
The light emitted by a halogen lamp was coupled to a
200-μm fiber and collimated to a 3-mm-diameter beam that illu-
minated the brain slice. The cleared sample was sandwiched
between two glass cover slips and placed in a custom-designed,
3-D printed sample holder with 2-mm spacing. Care was needed
when handling the samples cleared with CLARITY, since these
tissues lose their rigidity after the clearing process. To allow for
regions within the sample to be selectively illuminated by the
beam, the holder was placed onto two linear translation stages.
Transmitted light was fiber coupled and directed to a spectrom-
eter (MayaPro, Ocean Optics, Duiven, The Netherlands). Since
light scattering and absorption are wavelength dependent,10 data
were acquired with the spectrometer in the wavelength range of
400 to 1100 nm. Background and reference spectra were taken
with no sample in the holder and with BABB, respectively. Post-
processing of the data was performed with MATLAB. The
attenuation coefficient μT of each brain tissue slice with thick-
ness x (mm) was estimated using Eq. (1):
EQ-TARGET;temp:intralink-;e001;63;284μTðλÞ ¼ −
1
x
ln

IðλÞ − IbðλÞ
I0ðλÞ − IbðλÞ

; (1)
where I, I0, and Ib are the spectra acquired with light transmis-
sion through the sample, with light through the reference solu-
tion (BABB), and in the absence of light (the dark signal),
respectively, and λ is the wavelength.
3 Results and Discussion
Transmission spectra acquired in the brain samples showed that
the efficacy of optical clearing varied depending on the clearing
technique and tissue region (Fig. 2). Moreover, samples cleared
with pBABB and BABB resulted in lower attenuation coeffi-
cients than those cleared with CLARITY (Table 1). For instance,
the mean attenuation coefficients in the pons were 1.09 0.28
and 0.75 0.10 mm−1 for BABB and pBABB, respectively;
they were 1.89 0.19 mm−1 for CLARITY. Furthermore, the
shapes of the spectra acquired from CLARITY samples differed
prominently from that of brains cleared with BABB and
pBABB, with the attenuation peak occurring at a higher wave-
length than for BABB-cleared samples (480 nm for BABB,
compared with 560 nm for CLARITY in the pons). The dom-
inant contribution to the errors (Table 1) was intersample
variability.
The data presented in this study show that light attenuation in
cleared brain tissue was greatest in samples cleared with passive
CLARITY, and lowest in those cleared with pBABB or BABB.
The significantly lower absorption by BABB samples at higher
wavelengths (>600 nm) could perhaps be exploited for the opti-
mization of imaging of fluorophores with emission at such
wavelengths. The resulting absorption coefficients relative to
BABB- and pBABB-cleared samples present a considerable
disparity when compared with the ones relative to CLARITY-
cleared samples.
Structural tissue modifications such as dehydration or lipid
extraction lead to tissue swelling or shrinkage. Evaluation of the
change in the size of brain samples was assessed from tissue
cross-sectional areas before and after clearing. Measurements
showed a decrease in size with BABB and pBABB clearing
(58% and 56%, respectively), most likely caused by the dehy-
dration step, and a large increase in size was found with passive
CLARITY (229%). Regarding the swelling induced by the
CLARITY protocol, care is needed in the hydrogel preparation
step and in the incubation temperature of the sample for hydro-
gel polymerization (37°C). The same degree of shrinkage and
expansion was observed in cleared whole brains (data not
shown). Both of the size changes caused by the examined tech-
niques could be confounding factors in morphological studies
Fig. 1 Images of 2 mm mouse brain slices before and after optical
clearing. The brains, originally opaque (a), were optically cleared
with (b) BABB, (c) pBABB, and (d) CLARITY to achieve tissue trans-
parency. The areas where spectroscopic light attenuation measure-
ments were performed are shown in (a). The images have the same
spatial scale.
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Fig. 2 Light attenuation spectra acquired in three brain regions show the comparison of the tissue trans-
parency degree obtained with three clearing techniques. The spectra were calculated with Eq. (1) and
averaged over all measured brains.
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and should be taken into account when choosing a clearing
approach for a particular application.
Of the three brain regions investigated, the pons showed the
lowest clearing efficacy, most likely due to its greater gray mat-
ter density. Gray matter contains large quantities of myelin, a
lipid-based substance that contributes significantly to optical
scattering.10,11 In this study, a new clearing technique called
pBABB was also investigated, in which hydrogen peroxide is
added to the dehydration medium. This step is beneficial as it
enables the bleaching of endogenous tissue pigments. Moreover,
DMSO acts as a solvent increasing the clearing solution penetra-
tion without damaging the tissue.12 This methodology is also
particularly advantageous as it is straightforward and inexpensive,
and the clearing times are considerably shorter when compared
with techniques such as CLARITY. However, BABB, as with
most of the techniques that make use of organic solvents for
refractive index matching, has the main disadvantage of decreas-
ing the half-life of the fluorescent signal,13 most probably due to
peroxide contamination.14 Despite the highest degree of tissue
clearing which can be obtained with pBABB, this approach
is only applicable to autofluorescence studies to look at tissue
morphology, due to the bleaching step with hydrogen peroxide.
Conversely, the CLARITY protocol produces minimal protein
loss and preserves native fluorescence.5 The fluorescence
quenching that occurs with each clearing agent is an important
factor that needs to be taken into account when choosing a clear-
ing approach.15
4 Conclusion
This study demonstrated a novel method to quantify the efficacy
of optical clearing protocols, which is an essential step in the
process of choosing a clearing approach for a specific applica-
tion and in the stage of imaging data evaluation. The results
showed that the degree of clearing obtained with pBABB meth-
odology is greater than those given by BABB and CLARITY,
and that differences exist in the shape of absorption spectra, par-
ticularly at wavelengths greater than 600 nm. It is also been
shown that the level of optical clearing varies within the brain,
most likely due to the structure and composition of each particu-
lar area. The study focused on three optical clearing techniques
and on optical clearing of brain, but could easily be applied to
any other method or organ. This work could help guide the
choice of the most suitable optical clearing method for a specific
application. Furthermore, assessing the transparency of a tissue
is particularly important when imaging cleared samples with
systems like optical projection tomography or light sheet
microscopy, as reduced light scattering can lead to higher spatial
resolution and greater contrast.16
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Table 1 The wavelength for which the attenuation coefficient was a
maximum, λMAX, varied with brain region and clearing technique,
as did the corresponding attenuation coefficients, μT (λMAX)
(mean standard deviation).
Region Technique λMAX (nm) μT (λMAX) (mm−1)
Olfactory bulb BABB 476 0.55 0.23
pBABB 497 0.66 0.12
CLARITY 558 0.97 0.11
Pons BABB 487 1.09 0.28
pBABB 497 0.75 0.10
CLARITY 553 1.89 0.19
Cerebellum BABB 482 0.68 0.29
pBABB 497 0.70 0.09
CLARITY 549 1.38 0.22
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